Approval · Notice of Compliance 4512 · 1996
DIAHALT: Notice of Compliance 4512
Issued May 24, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4512
- Date
- May 24, 1996
- Company
- Wampole Canada Inc.
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Oral antidiarrheal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIAHALT | 02219484 | Cancelled Post Market |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB